Supplementary Figure from the Antitumor Effects of Vaccine-Activated CD8+ T Cells Associate with Weak TCR Signaling and Induction of Stem-Like Memory T Cells

Sha Wu,Wei Zhu,Yibing Peng,Lan Wang,Yuan Hong,Lei Huang,Dayong Dong,Junping Xie,Todd Merchen,Edward Kruse,Zong Sheng Guo,David Bartlett,Ning Fu,Yukai He

DOI: https://doi.org/10.1158/2326-6066.cir-17-0016

IF: 10.1

2017-01-01

Cancer Immunology Research

Abstract:Supplementary Figure from The Antitumor Effects of Vaccine-Activated CD8+ T Cells Associate with Weak TCR Signaling and Induction of Stem-Like Memory T Cells

What problem does this paper attempt to address?

Supplementary Data from Tumor-Derived Small Extracellular Vesicles Inhibit the Efficacy of CAR T Cells against Solid Tumors

Wenqun Zhong,Zebin Xiao,Zhiyuan Qin,Jingbo Yang,Yi Wen,Ziyan Yu,Yumei Li,Neil C. Sheppard,Serge Y. Fuchs,Xiaowei Xu,Meenhard Herlyn,Carl H. June,Ellen Puré,Wei Guo

DOI: https://doi.org/10.1158/0008-5472.23907869

2023-01-01

Abstract:Supplementary Figures and Figure Legends
Supplementary Figure from Dopamine Signaling Promotes Tissue-Resident Memory Differentiation of CD8+ T Cells and Antitumor Immunity

Yingshi Chen,Shu-Mei Yan,Zeyu Pu,Jinzhu Feng,Likai Tan,Yuzhuang Li,Hongrong Hu,Wenjing Huang,Yingtong Lin,Zhilin Peng,Xin He,Feng Huang,Hui Zhang,Yiwen Zhang

DOI: https://doi.org/10.1158/0008-5472.22431894

2023-01-01

Abstract:Supplementary Figure from Dopamine Signaling Promotes Tissue-Resident Memory Differentiation of CD8+ T Cells and Antitumor Immunity
Supplemental Figure S5 from Cytokine-like Molecule CCDC134 Contributes to CD8+ T-cell Effector Functions in Cancer Immunotherapy

Jing Huang,Lin Xiao,Xiaoting Gong,Wenwei Shao,Yanhui Yin,Qinyuan Liao,Yang Meng,Yingmei Zhang,Dalong Ma,Xiaoyan Qiu

DOI: https://doi.org/10.1158/0008-5472.22402073

2023-01-01

Abstract:Involvement of CD4+ T cells in the induction of antitumor activity by CCDC134.
Supplementary Figure Legend from Tumor Apoptotic Bodies Inhibit CTL Responses and Antitumor Immunity Via Membrane-Bound Transforming Growth Factor-β1 Inducing CD8+ T-Cell Anergy and CD4+ Tr1 Cell Responses

Yufeng Xie,Ou Bai,Jinying Yuan,Rajni Chibbar,Karen Slattery,Yangdou Wei,Yulin Deng,Jim Xiang

DOI: https://doi.org/10.1158/0008-5472.22378448

2023-01-01

Abstract:Supplementary Figure Legend from Tumor Apoptotic Bodies Inhibit CTL Responses and Antitumor Immunity via Membrane-Bound Transforming Growth Factor-β1 Inducing CD8+ T-Cell Anergy and CD4+ Tr1 Cell Responses
Supplementary Figure 2 from In Situ Vaccination with CD204 Gene-Silenced Dendritic Cell, not Unmodified Dendritic Cell, Enhances Radiation Therapy of Prostate Cancer

Chunqing Guo,Huanfa Yi,Xiaofei Yu,Daming Zuo,Jie Qian,Gary Yang,Barbara A. Foster,John R. Subjeck,Xiaolei Sun,Ross B. Mikkelsen,Paul B. Fisher,Xiang-Yang Wang

DOI: https://doi.org/10.1158/1535-7163.22497105.v1

2023-01-01

Abstract:PDF file, 1232K, SRA/CD204-targeted radio-immunotherapy enhances cytolytic activity of effector T cells.
Supplementary Data from Dopamine Signaling Promotes Tissue-Resident Memory Differentiation of CD8+ T Cells and Antitumor Immunity

Yingshi Chen,Shu-Mei Yan,Zeyu Pu,Jinzhu Feng,Likai Tan,Yuzhuang Li,Hongrong Hu,Wenjing Huang,Yingtong Lin,Zhilin Peng,Xin He,Feng Huang,Hui Zhang,Yiwen Zhang

DOI: https://doi.org/10.1158/0008-5472.22431897.v1

2023-01-01

Abstract:Supplementary Data from Dopamine Signaling Promotes Tissue-Resident Memory Differentiation of CD8+ T Cells and Antitumor Immunity
Supplementary Figures 1-2, Table 1 from Cancer Stem Cell Vaccination Confers Significant Antitumor Immunity

Ning Ning,Qin Pan,Fang Zheng,Seagal Teitz-Tennenbaum,Martin Egenti,Ji Yet,Mu Li,Christophe Ginestier,Max S. Wicha,Jeffrey S. Moyer,Mark E.P. Prince,Yingxin Xu,Xiao-Lian Zhang,Shiang Huang,Alfred E. Chang,Qiao Li

DOI: https://doi.org/10.1158/0008-5472.22395254.v1

2023-01-01

Abstract:PDF file - 185K
Supplementary Figure 2 from Cancer Immunotherapy Using in Vitro Genetically Modified Targeted Dendritic Cells

Huafeng Wei,Hao Wang,Bing Lu,Bohua Li,Sheng Hou,Weizhu Qian,Kexing Fan,Jianxin Dai,Jian Zhao,Yajun Guo

DOI: https://doi.org/10.1158/0008-5472.22375074

2023-01-01

Abstract:Supplementary Figure 2 from Cancer Immunotherapy Using In vitro Genetically Modified Targeted Dendritic Cells
Supplementary Figure 2 from Stat3 Inhibition Augments the Immunogenicity of B-cell Lymphoma Cells, Leading to Effective Antitumor Immunity

Fengdong Cheng,Hongwei Wang,Pedro Horna,Zi Wang,Bijal Shah,Eva Sahakian,Karrune V. Woan,Alejandro Villagra,Javier Pinilla-Ibarz,Said Sebti,Mitchell Smith,Jianguo Tao,Eduardo M. Sotomayor

DOI: https://doi.org/10.1158/0008-5472.22391792.v1

2023-01-01

Abstract:PDF file - 426K, Percent of T-cells
Supplementary Figure 4 from in Situ Vaccination with CD204 Gene-Silenced Dendritic Cell, Not Unmodified Dendritic Cell, Enhances Radiation Therapy of Prostate Cancer

Chunqing Guo,Huanfa Yi,Xiaofei Yu,Daming Zuo,Jie Qian,Gary Yang,Barbara A. Foster,John R. Subjeck,Xiaolei Sun,Ross B. Mikkelsen,Paul B. Fisher,Xiang-Yang Wang

DOI: https://doi.org/10.1158/1535-7163.22497099.v1

2023-01-01

Abstract:PDF file, 1187K, DC-SRA shRNA vaccination following RT upregulates Granzyme B expression in tumor-infiltrating CD8+ cells.
Supplemental Figure S4 from Cytokine-like Molecule CCDC134 Contributes to CD8+ T-cell Effector Functions in Cancer Immunotherapy

Jing Huang,Lin Xiao,Xiaoting Gong,Wenwei Shao,Yanhui Yin,Qinyuan Liao,Yang Meng,Yingmei Zhang,Dalong Ma,Xiaoyan Qiu

DOI: https://doi.org/10.1158/0008-5472.22402076.v1

2023-01-01

Abstract:Potent antitumor activity of CCDC134 in vivo.
Supplemental Figure S3 from Cytokine-like Molecule CCDC134 Contributes to CD8+ T-cell Effector Functions in Cancer Immunotherapy

Jing Huang,Lin Xiao,Xiaoting Gong,Wenwei Shao,Yanhui Yin,Qinyuan Liao,Yang Meng,Yingmei Zhang,Dalong Ma,Xiaoyan Qiu

DOI: https://doi.org/10.1158/0008-5472.22402079

2023-01-01

Abstract:Identification of established CCDC134 transgenic mice.
Supplementary Figure 2 from Combining DNA Vaccine and AIDA-1 in Attenuated Salmonella Activates Tumor-Specific CD4+ and CD8+ T-cell Responses

Yu Mei,Lixiang Zhao,Yonghao Liu,Huanle Gong,Yuan Song,Lei,Ying Zhu,Ziqi Jin,Shoubao Ma,Bo Hu,Qing Sun,Haiyan Liu

DOI: https://doi.org/10.1158/2326-6066.22539521

2023-01-01

Abstract:Representative flow cytometry plots for intracellular staining of TNF-alpha, IFN-gamma and IL-2 of CD4+ and CD8+ T cells from splenocytes on day 14 in lung metastasis model stimulated with B16-F10 lysates.
Supplementary Figure Legends 1-4 from Cancer Immunotherapy Using in Vitro Genetically Modified Targeted Dendritic Cells

Huafeng Wei,Hao Wang,Bing Lu,Bohua Li,Sheng Hou,Weizhu Qian,Kexing Fan,Jianxin Dai,Jian Zhao,Yajun Guo

DOI: https://doi.org/10.1158/0008-5472.22375065.v1

2023-01-01

Abstract:Supplementary Figure Legends 1-4 from Cancer Immunotherapy Using In vitro Genetically Modified Targeted Dendritic Cells
Supplementary Figure Legends from Cell-free Tumor Microparticle Vaccines Stimulate Dendritic Cells via cGAS/STING Signaling

Huafeng Zhang,Ke Tang,Yi Zhang,Ruihua Ma,Jingwei Ma,Yong Li,Shunqun Luo,Xiaoyu Liang,Tiantian Ji,Zhichao Gu,Jinzhi Lu,Wei He,Xuetao Cao,Yonghong Wan,Bo Huang

DOI: https://doi.org/10.1158/2326-6066.22538213

2023-01-01

Abstract:Supplementary Figure Legends
Supplementary Figure S9 from Effective Antitumor Immunity Can Be Triggered by Targeting VISTA in Combination with a TLR3-Specific Adjuvant

Bo Wang,Ziwei Ou,Wenlong Zhong,Lin Huang,Wenjian Liao,Yiyu Sheng,Zhixing Guo,Junyu Chen,Wenjuan Yang,Ke Chen,Xiaodong Huang,Tenghao Yang,Tianxin Lin,Jian Huang

DOI: https://doi.org/10.1158/2326-6066.24709704.v1

2023-01-01

Abstract:Combination (combo) of VISTA mAb 13F3/sODN-dsRNA with CD8+ T cell depletion induced TME changes in MB49 tumors
Supplementary Table 2 from Cancer Stem Cell Vaccination Confers Significant Antitumor Immunity

Ning Ning,Qin Pan,Fang Zheng,Seagal Teitz-Tennenbaum,Martin Egenti,Ji Yet,Mu Li,Christophe Ginestier,Max S. Wicha,Jeffrey S. Moyer,Mark E.P. Prince,Yingxin Xu,Xiao-Lian Zhang,Shiang Huang,Alfred E. Chang,Qiao Li

DOI: https://doi.org/10.1158/0008-5472.22395251.v1

2023-01-01

Abstract:PDF file - 57K
Supplementary Figure 1 from Stat3 Inhibition Augments the Immunogenicity of B-cell Lymphoma Cells, Leading to Effective Antitumor Immunity

Fengdong Cheng,Hongwei Wang,Pedro Horna,Zi Wang,Bijal Shah,Eva Sahakian,Karrune V. Woan,Alejandro Villagra,Javier Pinilla-Ibarz,Said Sebti,Mitchell Smith,Jianguo Tao,Eduardo M. Sotomayor

DOI: https://doi.org/10.1158/0008-5472.22391795.v1

2023-01-01

Abstract:PDF file - 111K, Viability and proliferation
Supplementary Fig. S7 from Orchestrated Codelivery of Peptide Antigen and Adjuvant to Antigen-Presenting Cells by Using an Engineered Chimeric Peptide Enhances Antitumor T-Cell Immunity

Haifeng Pan,Siyuan Yu,Haoyun Zhuang,Han Yang,Jinlu Jiang,Haihui Yang,Shuling Ren,Guoxing Luo,Xuan Yu,Shuping Chen,Yanhua Lin,Roufang Sheng,Shiyin Zhang,Quan Yuan,Chenghao Huang,Tianying Zhang,Tingdong Li,Shengxiang Ge,Jun Zhang,Ningshao Xia

DOI: https://doi.org/10.1158/2326-6066.26145096

2024-01-01

Abstract:Supplementary Fig. S7. GP33-related antigens and corresponding specific CD8 T cell responses.

Supplementary Figure from the Antitumor Effects of Vaccine-Activated CD8+ T Cells Associate with Weak TCR Signaling and Induction of Stem-Like Memory T Cells

Supplementary Data from Tumor-Derived Small Extracellular Vesicles Inhibit the Efficacy of CAR T Cells against Solid Tumors

Supplementary Figure from Dopamine Signaling Promotes Tissue-Resident Memory Differentiation of CD8+ T Cells and Antitumor Immunity

Supplemental Figure S5 from Cytokine-like Molecule CCDC134 Contributes to CD8+ T-cell Effector Functions in Cancer Immunotherapy

Supplementary Figure Legend from Tumor Apoptotic Bodies Inhibit CTL Responses and Antitumor Immunity Via Membrane-Bound Transforming Growth Factor-β1 Inducing CD8+ T-Cell Anergy and CD4+ Tr1 Cell Responses

Supplementary Figure 2 from <i>In Situ</i> Vaccination with <i>CD204</i> Gene-Silenced Dendritic Cell, not Unmodified Dendritic Cell, Enhances Radiation Therapy of Prostate Cancer

Supplementary Data from Dopamine Signaling Promotes Tissue-Resident Memory Differentiation of CD8<sup>+</sup> T Cells and Antitumor Immunity

Supplementary Figures 1-2, Table 1 from Cancer Stem Cell Vaccination Confers Significant Antitumor Immunity

Supplementary Figure 2 from Cancer Immunotherapy Using in Vitro Genetically Modified Targeted Dendritic Cells

Supplementary Figure 2 from Stat3 Inhibition Augments the Immunogenicity of B-cell Lymphoma Cells, Leading to Effective Antitumor Immunity

Supplementary Figure 4 from in Situ Vaccination with CD204 Gene-Silenced Dendritic Cell, Not Unmodified Dendritic Cell, Enhances Radiation Therapy of Prostate Cancer

Supplemental Figure S4 from Cytokine-like Molecule CCDC134 Contributes to CD8+ T-cell Effector Functions in Cancer Immunotherapy

Supplemental Figure S3 from Cytokine-like Molecule CCDC134 Contributes to CD8<sup>+</sup> T-cell Effector Functions in Cancer Immunotherapy

Supplementary Figure 2 from Combining DNA Vaccine and AIDA-1 in Attenuated Salmonella Activates Tumor-Specific CD4+ and CD8+ T-cell Responses

Supplementary Figure Legends 1-4 from Cancer Immunotherapy Using in Vitro Genetically Modified Targeted Dendritic Cells

Supplementary Figure Legends from Cell-free Tumor Microparticle Vaccines Stimulate Dendritic Cells via cGAS/STING Signaling

Supplementary Figure S9 from Effective Antitumor Immunity Can Be Triggered by Targeting VISTA in Combination with a TLR3-Specific Adjuvant

Supplementary Table 2 from Cancer Stem Cell Vaccination Confers Significant Antitumor Immunity

Supplementary Figure 1 from Stat3 Inhibition Augments the Immunogenicity of B-cell Lymphoma Cells, Leading to Effective Antitumor Immunity

Supplementary Fig. S7 from Orchestrated Codelivery of Peptide Antigen and Adjuvant to Antigen-Presenting Cells by Using an Engineered Chimeric Peptide Enhances Antitumor T-Cell Immunity

Supplementary Figure from the Antitumor Effects of Vaccine-Activated CD8+ T Cells Associate with Weak TCR Signaling and Induction of Stem-Like Memory T Cells

Supplementary Data from Tumor-Derived Small Extracellular Vesicles Inhibit the Efficacy of CAR T Cells against Solid Tumors

Supplementary Figure from Dopamine Signaling Promotes Tissue-Resident Memory Differentiation of CD8+ T Cells and Antitumor Immunity

Supplemental Figure S5 from Cytokine-like Molecule CCDC134 Contributes to CD8+ T-cell Effector Functions in Cancer Immunotherapy

Supplementary Figure Legend from Tumor Apoptotic Bodies Inhibit CTL Responses and Antitumor Immunity Via Membrane-Bound Transforming Growth Factor-β1 Inducing CD8+ T-Cell Anergy and CD4+ Tr1 Cell Responses

Supplementary Figure 2 from <i>In Situ</i> Vaccination with <i>CD204</i> Gene-Silenced Dendritic Cell, not Unmodified Dendritic Cell, Enhances Radiation Therapy of Prostate Cancer

Supplementary Data from Dopamine Signaling Promotes Tissue-Resident Memory Differentiation of CD8<sup>+</sup> T Cells and Antitumor Immunity

Supplementary Figures 1-2, Table 1 from Cancer Stem Cell Vaccination Confers Significant Antitumor Immunity

Supplementary Figure 2 from Cancer Immunotherapy Using in Vitro Genetically Modified Targeted Dendritic Cells

Supplementary Figure 2 from Stat3 Inhibition Augments the Immunogenicity of B-cell Lymphoma Cells, Leading to Effective Antitumor Immunity

Supplementary Figure 4 from in Situ Vaccination with CD204 Gene-Silenced Dendritic Cell, Not Unmodified Dendritic Cell, Enhances Radiation Therapy of Prostate Cancer

Supplemental Figure S4 from Cytokine-like Molecule CCDC134 Contributes to CD8+ T-cell Effector Functions in Cancer Immunotherapy

Supplemental Figure S3 from Cytokine-like Molecule CCDC134 Contributes to CD8&lt;sup&gt;+&lt;/sup&gt; T-cell Effector Functions in Cancer Immunotherapy

Supplementary Figure 2 from Combining DNA Vaccine and AIDA-1 in Attenuated Salmonella Activates Tumor-Specific CD4+ and CD8+ T-cell Responses

Supplementary Figure Legends 1-4 from Cancer Immunotherapy Using in Vitro Genetically Modified Targeted Dendritic Cells

Supplementary Figure Legends from Cell-free Tumor Microparticle Vaccines Stimulate Dendritic Cells via cGAS/STING Signaling

Supplementary Figure S9 from Effective Antitumor Immunity Can Be Triggered by Targeting VISTA in Combination with a TLR3-Specific Adjuvant

Supplementary Table 2 from Cancer Stem Cell Vaccination Confers Significant Antitumor Immunity

Supplementary Figure 1 from Stat3 Inhibition Augments the Immunogenicity of B-cell Lymphoma Cells, Leading to Effective Antitumor Immunity

Supplementary Fig. S7 from Orchestrated Codelivery of Peptide Antigen and Adjuvant to Antigen-Presenting Cells by Using an Engineered Chimeric Peptide Enhances Antitumor T-Cell Immunity

Supplemental Figure S3 from Cytokine-like Molecule CCDC134 Contributes to CD8<sup>+</sup> T-cell Effector Functions in Cancer Immunotherapy